FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

897234001: Satralizumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4033009019 Satralizumab (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4033010012 Satralizumab en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Satralizumab (substance) Is a Immunosuppressant (substance) true Inferred relationship Some
Satralizumab (substance) Is a Monoclonal antibody true Inferred relationship Some
Satralizumab (substance) Is a Interleukin 6 receptor antagonist true Inferred relationship Some
Satralizumab (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Interleukin 6 receptor antagonist (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Satralizumab-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Satralizumab (substance) Inferred relationship Some 1
Satralizumab only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Satralizumab (substance) Inferred relationship Some 1
Satralizumab-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Satralizumab (substance) Inferred relationship Some 1
Product containing only satralizumab in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Satralizumab (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start